Ειδήσεις: BIOGEN | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 15:40 statnews.com

STAT+: Psychedelic biotechs face scrutiny over YouTube promos

psychedelic biotechs YouTube promotions regulatory scrutiny pharma acquisitions Eli Lilly Biogen

31/03 15:07 marketwatch.com

Biogen will acquire a drug company for $5.6 billion to expand work in kidney diseases

Biogen Apellis kidney disease drug acquisition biotechnology $5.6 billion

31/03 14:47 statnews.com

STAT+: Biogen to acquire immunology biotech Apellis for $5.6 billion

Biogen Apellis acquisition immunology macular degeneration Syfovre

30/03 16:34 statnews.com

STAT+: Biogen lupus drug improves skin clearance in mid-stage study

Biogen lupus skin clearance Insilico Medicine Eli Lilly AI drug discovery

28/03 10:30 defenseworld.net

Generali Investments CEE investicni spolecnost a.s. Purchases 4,797 Shares of Biogen Inc. $BIIB

Generali Investments Biogen Inc 13F filing Q4 holdings Advisory Services Network biotech investment

20/03 09:20 defenseworld.net

Biogen Inc. $BIIB Stake Raised by AIA Group Ltd

Biogen AIA Group institutional investor hedge funds stake increase biotech

19/03 07:03 defenseworld.net

Biogen Conference: Tau ASO CELIA Updates, Pre-Symptomatic Leqembi, SMA Phase 3 Plans

Biogen tau ASO Alzheimer’s disease SMA Leqembi immunology

18/03 09:06 defenseworld.net

Biogen (NASDAQ:BIIB) Price Target Raised to $150.00 at HSBC

Biogen HSBC Jefferies Barclays price target biotechnology

18/03 09:06 defenseworld.net

Biogen (NASDAQ:BIIB) Price Target Raised to $150.00 at HSBC

Biogen HSBC Jefferies Barclays price target biotechnology

Loading...